Financial Section - Merck.com
20 Merck & Co., Inc. Annual Report 2002 live virus vaccine for the prevention of chickenpox, M-M-R II, a pediatric vaccine for measles, mumps and rubella, and
Download Financial Section - Merck.com
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEYTRUDAsafely and effectively. See full prescribing
M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS …
www.merck.com1 M-M-R®II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE) DESCRIPTION M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination ...
Medication Guide JANUMET - Merck.com
www.merck.comMedication Guide JANUMET®XR (JAN-you-met XR) (sitagliptin and metformin hydrochloride extended-release) Tablets Read this Medication Guide carefully before you start taking JANUMETXR and each time you get a refill.
Medication Guide - Merck.com
www.merck.com1 Medication Guide JANUVIA® (jah-NEW-vee-ah) (sitagliptin) Tablets Read this Medication Guide carefully before you start taking JANUVIA and each time you get a …
Patient Information EMEND (EE mend) (aprepitant) …
www.merck.comPatient Information EMEND® (EE mend) (aprepitant) capsules EMEND® (EE mend) (aprepitant) for oral suspension Read this Patient Information before you start taking EMEND and each time you get a refill.
FDA-Approved Patient Labeling - Merck.com
www.merck.com1 FDA-Approved Patient Labeling NEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only NEXPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases.
Proposed Prescribing Information (USPI) Singulair
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Asthma SINGULAIR® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12months of age and older.
For injection: 100 mg of lyophilized infliximab-abda …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing
GARDASIL9 - Merck & Co.
www.merck.com1 Patient Information about GARDASIL®9 (pronounced “gard-Ah-sill nīn”) (Human Papillomavirus 9-valent Vaccine,Recombinant) Read this information with care before getting GARDASIL®9.
Related documents
Sunoion Support
www.sunovionsupport.com2 Sunoion Support® PSPN ASSSAN PGAM Patient’s Insurance Information 1. Is the patient enrolled in Medicare/Medicaid? YES NO 2. Does the patient have prescription drug coverage through any other benefit program that helps pay for prescription
Dental management of patients before and after renal ...
www.sbdmj.comStomatologija, Baltic Dental and Maxillofacial Journal, 2011, Vol. 13, No. 4 107 Dental management of patients before and after renal transplantation
(OWTOIMPROVETHEUSEOF - WHO
www.who.inti (OWTOIMPROVETHEUSEOF MEDICINESBYCONSUMERS Andrew Chetley Healthlink Worldwide Anita Hardon University of Amsterdam Catherine Hodgkin Royal Tropical Institute, the Netherlands
Vaccine Fact Sheet - EZIZ
eziz.orgBrand Name Menactra Manufacturer Abbreviation MenACWY-CRM Protects Against Invasive Meningococcal Disease caused by Routine Schedule One (1) dose at …
Developing Data Collection Instruments - World Bank
siteresources.worldbank.org103 8 Developing Data Collection Instruments M onitoring and evaluation rely on data collection instruments to elicit and record information. There are various types of instruments
chapter 4 National medicine policy - WHO
apps.who.int4 / National medicine policy 4.3 stated: a national medicine policy should ensure that effec- tive and safe medicines of good quality are accessible and affordable to the entire population and that they are - ratio nally used. The 1980s saw the idea of an NMP emerging as a posi-tive concept, and the World Health Organization (WHO)
Generic and Brand Name Drugs: Understanding the Basics
www.dbsalliance.orgGeneric and Brand Name Drugs: Understanding the Basics We’ve been there. We can help.
contact - WHO
apps.who.intContact n°183 –Autumn/Winter 2006 3 EDITORIAL wards changing specific problems; the amount of irrational use, so that the size of the problem is known and the impact of the strategies can be moni-tored; the reasons why medicines are used irrationally, so that appropriate, effective